Literature DB >> 23533173

Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models.

Brunella Cristofaro1, Yu Shi, Marcella Faria, Steven Suchting, Aurelie S Leroyer, Alexandre Trindade, Antonio Duarte, Ann C Zovein, M Luisa Iruela-Arispe, Lina R Nih, Nathalie Kubis, Daniel Henrion, Laurent Loufrani, Mihail Todiras, Johanna Schleifenbaum, Maik Gollasch, Zhen W Zhuang, Michael Simons, Anne Eichmann, Ferdinand le Noble.   

Abstract

Arteriogenesis requires growth of pre-existing arteriolar collateral networks and determines clinical outcome in arterial occlusive diseases. Factors responsible for the development of arteriolar collateral networks are poorly understood. The Notch ligand Delta-like 4 (Dll4) promotes arterial differentiation and restricts vessel branching. We hypothesized that Dll4 may act as a genetic determinant of collateral arterial networks and functional recovery in stroke and hind limb ischemia models in mice. Genetic loss- and gain-of-function approaches in mice showed that Dll4-Notch signaling restricts pial collateral artery formation by modulating arterial branching morphogenesis during embryogenesis. Adult Dll4(+/-) mice showed increased pial collateral numbers, but stroke volume upon middle cerebral artery occlusion was not reduced compared with wild-type littermates. Likewise, Dll4(+/-) mice showed reduced blood flow conductance after femoral artery occlusion, and, despite markedly increased angiogenesis, tissue ischemia was more severe. In peripheral arteries, loss of Dll4 adversely affected excitation-contraction coupling in arterial smooth muscle in response to vasopressor agents and arterial vessel wall adaption in response to increases in blood flow, collectively contributing to reduced flow reserve. We conclude that Dll4-Notch signaling modulates native collateral formation by acting on vascular branching morphogenesis during embryogenesis. Dll4 furthermore affects tissue perfusion by acting on arterial function and structure. Loss of Dll4 stimulates collateral formation and angiogenesis, but in the context of ischemic diseases such beneficial effects are overruled by adverse functional changes, demonstrating that ischemic recovery is not solely determined by collateral number but rather by vessel functionality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23533173      PMCID: PMC4074271          DOI: 10.1242/dev.092304

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  38 in total

1.  Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements.

Authors:  Pascal Meier; Steffen Gloekler; Rainer Zbinden; Sarah Beckh; Stefano F de Marchi; Stephan Zbinden; Kerstin Wustmann; Michael Billinger; Rolf Vogel; Stéphane Cook; Peter Wenaweser; Mario Togni; Stephan Windecker; Bernhard Meier; Christian Seiler
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

Review 2.  Angiogenesis: a team effort coordinated by notch.

Authors:  L-K Phng; Holger Gerhardt
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

3.  Akt1 is critical for acute inflammation and histamine-mediated vascular leakage.

Authors:  Annarita Di Lorenzo; Carlos Fernández-Hernando; Giuseppe Cirino; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

4.  Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.

Authors:  Jason A Clayton; Dan Chalothorn; James E Faber
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

Review 5.  Arterial-venous specification during development.

Authors:  Matthew R Swift; Brant M Weinstein
Journal:  Circ Res       Date:  2009-03-13       Impact factor: 17.367

6.  Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension.

Authors:  Cécile Cayla; Mihail Todiras; Radu Iliescu; Vera V Saul; Volkmar Gross; Bernhard Pilz; Guixuan Chai; Vanessa F Merino; João B Pesquero; Ovidiu C Baltatu; Michael Bader
Journal:  FASEB J       Date:  2007-02-08       Impact factor: 5.191

7.  Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice.

Authors:  Urban Deutsch; Thorsten M Schlaeger; Bénédicte Dehouck; Axinia Döring; Silke Tauber; Werner Risau; Britta Engelhardt
Journal:  Exp Cell Res       Date:  2008-01-15       Impact factor: 3.905

8.  Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos.

Authors:  Alexandre Trindade; S Ram Kumar; Jeffrey S Scehnet; Luis Lopes-da-Costa; Jorg Becker; Weidong Jiang; Ren Liu; Parkash S Gill; Antonio Duarte
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

9.  The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.

Authors:  Rui Benedito; Cristina Roca; Inga Sörensen; Susanne Adams; Achim Gossler; Marcus Fruttiger; Ralf H Adams
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

Review 10.  Collateral circulation: past and present.

Authors:  Wolfgang Schaper
Journal:  Basic Res Cardiol       Date:  2008-12-20       Impact factor: 17.165

View more
  38 in total

1.  Genetic variation in retinal vascular patterning predicts variation in pial collateral extent and stroke severity.

Authors:  Pranay Prabhakar; Hua Zhang; De Chen; James E Faber
Journal:  Angiogenesis       Date:  2014-11-05       Impact factor: 9.596

2.  DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.

Authors:  Bahman Rostama; Jacqueline E Turner; Guy T Seavey; Christine R Norton; Thomas Gridley; Calvin P H Vary; Lucy Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-15       Impact factor: 8.311

Review 3.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

4.  The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.

Authors:  Hemabindu Chintala; Izabela Krupska; Lulu Yan; Lester Lau; Maria Grant; Brahim Chaqour
Journal:  Development       Date:  2015-05-22       Impact factor: 6.868

5.  Variants of Rab GTPase-Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke.

Authors:  Jennifer L Lucitti; Robert Sealock; Brian K Buckley; Hua Zhang; Lin Xiao; Andrew C Dudley; James E Faber
Journal:  Stroke       Date:  2016-11-03       Impact factor: 7.914

6.  Fox(y) regulators of VEGF receptors.

Authors:  Nicolas Ricard; Michael Simons
Journal:  Circ Res       Date:  2014-09-26       Impact factor: 17.367

7.  Laminin-dystroglycan signaling regulates retinal arteriogenesis.

Authors:  Saptarshi Biswas; Jared Watters; Galina Bachay; Shweta Varshney; Dale D Hunter; Huaiyu Hu; William J Brunken
Journal:  FASEB J       Date:  2018-06-06       Impact factor: 5.191

8.  Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice.

Authors:  Joshua K Meisner; Brian H Annex; Richard J Price
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

9.  Skeletal myofiber VEGF is essential for the exercise training response in adult mice.

Authors:  Hamid Delavar; Leonardo Nogueira; Peter D Wagner; Michael C Hogan; Daniel Metzger; Ellen C Breen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

10.  Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.

Authors:  David T Paik; Meena Rai; Sergey Ryzhov; Lehanna N Sanders; Omonigho Aisagbonhi; Mitchell J Funke; Igor Feoktistov; Antonis K Hatzopoulos
Journal:  Circ Res       Date:  2015-09-03       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.